CD40: A pivotal receptor in the determination of life/death decisions in B lymphocytes

International Reviews of Immunology

Volumn 15, Issue 1-2, 1997, Pages 5-31

  Klaus, Gerry G B ^a   Choi, Michael S K ^a   Lam, Eric W F ^b   Johnson Léger, Caroline ^b   Cliff, Jacqueline ^b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Apoptosis; B lymphocytes; CD40; Cytokines; Signal transduction

Indexed keywords

EID: 0030986884     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189709068169     Document Type: Article

References (95)

1. Clark, E.A., CD40: a cytokine receptor in search of a ligand. Tissue Antigens 36, 33-36, 1990.
2. Stamenkovic, I., Clark, E.A. and Seed, B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8, 1403-1410, 1989.
3. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.P., Van Kooten, C., Liu, Y.J., Rousset, F. and Saeland, S. The CD40 antigen and its ligand. Ann. Rev. Immunol. 12, 881-922, 1994.
4. Noelle, R.J. and Snow, E.C. T helper cell-dependent B cell activation. FASEB J. 5, 2770-2776, 1991.
5. Parker, D.C. T cell-dependent B cell activation. Annu. Rev. Immunol. 11, 331-360, 1993.
6. Brian, A.A. Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells. Proc. Natl. Acad. Sci. USA 85, 564-568, 1988.
7. Armitage, R.J., Fanslow, W.C., Strockbine, L., Sato, T.A., Clifford, K.N., Macduff, B.M., Anderson, D.M., Gimpel, S.D., Davis-Smith, T., Maliszewski, C.R., Clark, E.A., Smith, C.A., Grabstein, K.H., Cosman, D. and Spriggs, M.K. Molecular and biological characterization of a murine ligand for CD40 Nature 357, 80-82, 1992.
8. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovicn, A., Nonoyama, S., Bajorath, J., Grosmaire, L.S., Stenkamp, R., Neubauer, M. et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked Hyper-IgM Syndrome. Cell 72, 291-300, 1993.
9. DiSanto, J.P., Bonnefoy, J.Y., Gauchat, J.F., Fischer, A. and de Saint Basile, G. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361, 541-543, 1993.
10. Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T. and Kikutani, H. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178, 1994.
11. Xu, J., Foy, T.M., Laman, J.D., Elliott, E.A., Dunn, J.J., Waldschmidt, T.J., Elsemore, J., Noelle, R.J. and Flavell, R.A. Mice deficient for the CD40 Ligand. Immunity 1, 423-431, 1994.
12. Foy, T.M., Shepherd, D.M., Durie, F.H., Aruffo, A , Ledbetter, J.A. and Noelle, R.J. In Vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178, 1567-1575, 1993.
13. Foy, T.M., Laman, J.D., Ledbetter, J.A., Aruffo, A., Claassen, E and Noelle, R.J. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180, 157-163, 1994.
14. Banchereau, J., Depaoli, P., Valle, A., Garcia, E. and Rousset, F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251, 70-72, 1991.
15. Liu, Y.J., Joshua, D.E., Williams, G.T., Smith, C.A., Gordon, J. and MacLennan, I.C. Mechanism of antigen-driven selection in germinal centres. Nature 342, 929-931, 1989.
16. Saeland, S., Duvert, V., Caux, C., Pandrau, D., Favre, C., Valle, A., Durand, I., Charbord, P., De Vries, J. and Banchereau, J. Distribution of surface-membrane molecules on bone marrow and cord blood CD34 + hematopoietic cells. Exp. Hematol. 20, 24-33, 1992.
17. Hasbold, J., Johnson-Leger, C., Atkins, C.J., Clark, E.A. and Klaus, G.G.B. Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur. J. Immunol. 24, 1835-1842, 1994.
18. Van den Berg, T.K., Hasbold, J., Renardel de Lavallette, C., Dopp, E.A., Dijkstra, C.D. and Klaus, G.G.B. Immunology 1996 (in press).
19. Wheeler, K., Pound, J.D. and Jefferis, R. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur. J. Immunol. 23, 1165-1168, 1993.
20. Arpin, C., Dechanet, J., Van Kooten, C., Merville, P., Grouard, G., Briere, F., Banchereau, J. and Liu, Y.J. Generation of memory B cells and plasma cells in vitro. Science 268, 720-722, 1995.
21. Maliszewski, C.R., Grabstein, K., Fanslow, W.C., Armitage, R., Spriggs, M.K. and Sato, T.A. Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines. Eur. J. Immunol. 23, 1044-1049, 1993.
22. Grabstein, K.H., Maliszewski, C.R., Shanebeck, K., Sato, T.A., Spriggs, M.K., Fanslow, W.C. and Armitage, R.J. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. J. Immunol. 150, 3141-3147, 1993.
23. Mosmann, T.R. and Coffman, R.L., Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46, 111-147, 1989
24. Snapper, C.M. and Mond, J.J. Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14, 15-17, 1993.
25. Germann, T., Bongartz, M., Dlugonska, H., Hess, H., Schmitt, E., Kolbe, L., Kolsch, E., Podlaski, F.J., Gately, M.K. and Rude, E. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25, 823-829, 1995.
26. Finkelman, F.D., Holmes, J., Katona, I.M., Urban, J.F., Beckman, M.P., Park, L.S., Schooley, K.A., Mosmann, T.R. and Paul, W.E. Lymphokine control of in vivo immunoglobulin isotype selection. Ann. Rev. Immunol. 8, 303-333, 1990.
27. Mond, J.J., Finkelman, F.D., Sarma, C., Ohara, J. and Serrate, S. Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody. J. Immunol. 135, 2513-2517, 1985
28. Sidman, C.L., Marshall, J.D., Schultz, L.D., Gray, P.W. and Johnson, H.M. Gamma-interferon is one of several direct B cell-maturing lymphokines. Nature 309, 801-803, 1984.
29. Abed, N.S., Chace, J.H., Fleming, A.L. and Cowdery, J.S. Interferon-gamma regulation of B lymphocyte differentiation: activation of B cells is a prerequisite for IFN-gamma-mediated inhibition of B cell differentiation. Cell Immunol. 153, 356-366, 1994.
30. Choi, M.S.K., Brines, R.D., Holman, M.J. and Klaus, G.G.B. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 Ligand in conjunction with IL-4. Immunity 1, 179-187, 1994.
31. Armitage, R.J., Macduff, B.M., Spriggs, M.K. and Fanslow, W.C. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 150, 3671-3680, 1993.
32. Peitsch, M.C. and Jongeneel, C.V. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int. Immunol. 5, 233-238, 1993.
33. Smith, C. A., Farrah, T. and Goodwin, R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959-962, 1994.
34. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243, 1991.
35. Uckun, F.M., Schieven, G.L., Dibirdik, I., Chandan-Langlie, M., Tuel-Ahlgren, L. and Ledbetter, J.A. Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the Pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 266, 17478-17485, 1991.
36. Knox, K.A. and Gordon, J. Protein tyrosine phosphorylation is mandatory for CD40-mediated rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 23, 2578-2584, 1993.
37. Faris, M., Gaskin, F., Parsons, J.T. and Man Fu, S. CD40 Signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of Tyrosine-phosphorylated proteins including protein Tyrosine Kinase Lyn, Fyn, and Syk and the appearance of a 28-kD Tyrosine phosphorylated protein. J. Exp. Med. 179, 1923-1931, 1994.
38. Ren, C.L., Mono, T., Fu, S.M. and Geha, R.S. Signal transduction via CD40 invloves activation of lyn Kinase and Phosphatidylinositol-3-kinase, and phosphorylation of Phospholipase Cγ2. J. Exp. Med. 179, 673-680, 1994.
39. Clark, E.A., Shu, G.L., Luscher, B., Draves, K.E., Banchereau, J., Ledbetter, J.A. and Valentine, M.A. Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals. J. Immunol. 143, 3873-3880, 1989.
40. Gruber, M.F., Bjorndahl, J.M., Nakamura, S. and Fu, S.M. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies. J. Immunol. 142, 4144-4152, 1989.
41. Berberich, I., Shu, G.L. and Clark, E.A., Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J. Immunol. 153, 4357-4366, 1994.
42. Inui, S., Kaisho, T., Kikutani, H., Stamenkovic, I., Seed, B., Clark, E.A. and Kishimoto, T. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur. J. Immunol. 20, 1747-1753, 1990.
43. Sato, T., Irie, S. and Reed, J.C. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358, 113-118, 1995.
44. Hu, H.M., O'Rourke, K., Boguski, M.S. and Dixit, V.M. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269, 30069-30072, 1994.
45. Cheng, G., Cleary, A.M., Ye, Z.S., Hong, D.I., Lederman, S. and Baltimore, D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494-1498, 1995.
46. Rothe, M., Sarma, V., Dixit, V.M. and Goeddel, D.V. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269, 1424-1426, 1995.
47. Klaus, G.G.B., Choi, M.S.K. and Holman, M. Properties of mouse CD40. Ligation of CD40 activates B cells via a Ca(++)-dependent, FK506-sensitive pathway. Eur. J. Immunol. 24, 3229-3232, 1994.
48. Klaus, G.G.B. Cyclosporine-sensitive and cyclosporine-insensitive modes of B cell stimulation. Transplantation 46, 11S-14S, 1988.
49. Rao, A. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15, 274-281, 1994.
50. Francis, D.A., Karras, J.G., Ke, X.-Y., Sen, R. and Rothstein, T.L. Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7, 151-161, 1995.
51. Lalmanach Girard, A.C., Chiles, T.C., Parker, D.C. and Rothstein, T.L., T cell-dependent induction of Nf-κB in B cells. J. Exp. Med. 177, 1215-1219, 1993.
52. Burdin, N., Van Kooten, C., Galibert, L., Abrams, J.S., Wijdenes, J., Banchereau, J. and Rousset, F. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol. 154, 2533-2544, 1995.
53. Vercelli, D., Jabara, H.H., Arai, K., Yokota, T. and Geha, R. Endogenous interleukin 6 plays an obligatory role in inter-leukin 4-dependent human IgE synthesis. Eur. J. Immunol. 19, 1419-1424, 1989.
54. Jabara, H.H., Fu, S.M., Geha, R.S. and Vercelli, D. CD40 and IgE: Synergism between anti-CD40 monoclonal antibody and Interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172, 1861-1864, 1990.
55. Worm, M. and Geha, R.S. CD40 ligation induces lymphotoxin alpha gene expression in human B cells. Int. Immunol. 6, 1883-1890, 1994.
56. Boussiotis, V.A., Nadler, L.M., Strominger, J.L. and Goldfeld, A.E. Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc. Natl. Acad. Sci. USA 91, 7007-7011, 1994.
57. Cohen, J.J., Duke, R.C., Fadok, V.A. and Sellins, K S. Apoptosis and programmed cell death in immunity. Ann. Rev. Immunol. 10, 267-293, 1992.
58. MacLennan, I.C. Germinal centers. Annu. Rev. Immunol. 12, 117-139, 1994.
59. Benhamou, L.E., Cazenave, P.A. and Sarthou, P. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur. J Immunol. 20, 1405-1408, 1990.
60. Hasbold, J. and Klaus, G.G.B. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur. J. Immunol. 20, 1685-1690, 1990.
61. Tsubata, T., Wu, J. and Honjo, T. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 364, 645-648, 1993.
62. L in CD40-mediated rescue from anti-μ-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 25, 1352-1357, 1995.
63. Cory, S. Regulation of lymphocyte survival by the BCL-2 gene family. Annu. Rev. Immunol 13, 513-543, 1995.
64. Cuende, E., Ales Martinez, J.E., Ding, L., Gonzalez Garcia, M., Martinez, C. and Nunez, G. Programmed cell death by bcl-2-dependent and independent mechanisms in B lymphoma cells. EMBO J. 12, 1555-1560, 1993.
65. Gottschalk, A.R., McShan, C.L., Merino, R., Nunez, G. and Quintans, J. Physiological cell death in B lymphocytes: 1. Differential susceptibility of WEHI-231 sublines to anti-1g induced physiological cell death and lack of correlation with bcl-2 expression. Int. Immunol. 6, 121-130, 1994.
66. Boise, L.H., Gottschalk, A.R., Quintans, J. and Thompson, C.B. Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr. Top. Microbiol. Immunol. 200, 107-121, 1995.
67. Boise, L.H., Gonzalez Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G. and Thompson, C.B., bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608, 1993.
68. Wang, Z., Karras, J.G., Howard, R.G. and Rothstein, T.L. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. J. Immunol. 155, 3722-3725, 1995.
69. 2+ fluxes. Proc. Natl. Acad. Sci. USA 91, 6569-6573, 1994.
70. Lam, E.W.-F. and La Thangue, N.B. DP and E2F proteins, coordinating transcription with cell cycle progression. Curr. Opin. Cell Biol. 6, 859-866, 1994.
71. Joseph, L.F., Ezhevsky, S. and Scott, D.W. Lymphoma models for B-cell activation and tolerance: anti-immunoglobuhn M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1. Cell Growth Differ. 6, 51-57, 1995.
72. Warner, G.L., Ludlow, J.W., Nelson, D.A., Gaur, A. and Scott, D.W. Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent. Cell Growth Differ. 3, 175-181, 1992.
73. Hijmans, E.M., Voorhoeve, P.M., Beijersbergen, R.L., Veer, L.J. and Bernards, R. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15, 3082-3089, 1995.
74. Vairo, G., Livingston, D.M. and Ginsburg, D. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9, 869-881, 1995.
75. Illera, V.A., Perandones, C.E., Stunz, L.L., Mower, D.A. and Ashman, R.F. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J. Immunol. 151, 2965-2973, 1993.
76. Parry, S.L , Hasbold, J., Holman, M. and Klaus, G.G.B. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J. Immunol. 152, 2821-2829, 1994.
77. Parry, S.L., Holman, M.J., Hasbold, J. and Klaus, G.G.B. Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes. Eur. J. Immunol. 24, 974-979, 1994.
78. Strasser, A. Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms. Curr. Opin. Immunol. 7, 228-234, 1995.
79. Watanabe, D., Suda, T. and Nagata, S. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int. Immunol. 7, 1949-1956, 1995.
80. Mandik, L., Nguyen, K.-A. and Erikson, J. Fas receptor expression on B-lineage cells. Eur. J. Immunol. 25, 3148-3154, 1995.
81. + T cells. Nature 376, 181-183, 1995.
82. Rothstem, T.L., Wang, J.K., Panka, D.J., Foote, L.C., Wang, Z., Stanger, B., Cui, H., Ju, S.T. and Marshak Rothstein, A. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163-165, 1995.
83. Merino, R., Ding, L., Veis, D.J., Korsmeyer, S.J. and Nunez, G. Developmental regulation of the Bc1-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 13, 683-691, 1994.
84. Choi, M.S.K., Holman, M., Atkins, C.J. and Klaus, G.G.B. Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli. Eur. J. Immunol. 1996.
85. Ohta, K., Iwai, K., Kasahara, Y., Taniguchi, N., Krajewski, S., Reed, J.C. and Miyawaki, T. Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues. Int. Immunol. 7, 1817-1825, 1995
86. Veis, D.J., Sorensen, C.M., Shutter, J.R. and Korsmeyer, S.J. Bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-240, 1993.
87. Nakayama, K., Negishi, I., Kuida, K., Shinkai, Y., Louie, M.C., Fields, L.E., Lucas, P.J., Stewart, V., Alt, F.W. et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261, 1584-1588, 1993.
88. Motoyama, N., Wang, F., Roth, K.A., Sawa, H., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S. et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267, 1506-1510, 1995.
89. Kinnon, C., Hinshelwood, S., Levinsky, R.J. and Lovering, R.C. X-linked agammaglobulinemia - gene cloning and future prospects. Immunol. Today 14, 554-558, 1993.
90. Scher, I. The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv. Immunol. 33, 1-71, 1982.
91. Santos Argumedo, L., Lund, F.E., Heath, A.W., Solvason, N., Wu, W.W., Grimaldi, J.C., Parkhouse, R.M. and Howard, M. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. Int. Immunol. 7, 163-170, 1995.
92. Thomas, J.D., Sideras, P., Smith, C.I.E., Vorechovsky, I., Chapman, V. and Paul, W.E. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261, 355-358, 1993.
93. Rawlings, D.J., Saffran, D.C., Tsukada, S., Largaespada, D.A., Grimaldi, J.C., Cohen, L., Mohr, R.N., Bazan, J.F., Howard, M., Copeland, N.G., Jenkins, N.A. and Witte, O.N. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261, 358-361, 1993.
94. Hasbold, J. and Klaus, G.G.B. B cells from CBA/N mice do not proliferate following ligation of CD40. Eur. J. Immunol. 24, 152-157, 1994.
95. Mond, J.J., Schaefer, M.E., Smith, J. and Finkelman, F.D Lyb-5-B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig. J. Immunol. 31, 2107-2109, 1983.